Pharmaceuticals

With gonorrhea becoming increasingly resistant to antibiotics, a new $2.6M grant fuels the development of a promising preventative vaccine platform.

Umoja Biopharma's UB-VV500 aims to revolutionize myeloma care by creating a dual-antigen CAR T therapy directly inside the patient's body.

New Phase 2a data reveals Oruka Therapeutics' ORKA-001 achieved complete skin clearance in nearly two-thirds of patients, positioning it as a potential game-changer.

A new report reveals payers are rewriting drug benefit rules, sacrificing rebates for more control as they grapple with the high cost of new therapies.

With investments exceeding $1B, PCI Pharma Services is expanding its US sterile manufacturing, tackling supply chain risks and boosting domestic production.

Once a student finding refuge at Milton Hershey School, Maria Trinh Kraus now chairs its boards, shaping the very legacy that transformed her own life.

A new partnership brings a single-dose treatment for common, serious infections to Sub-Saharan Africa, a region with high prevalence and unmet medical needs.

A major trial shows once-weekly rezafungin is as effective as daily drugs for preventing deadly fungal infections, heralding a new era for patient care.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

A landmark study reveals essential phospholipids significantly reduce liver fat and fatigue in MASLD patients, offering a new tool against a silent epidemic.

A Cambridge firm's novel intracoronary liquid biopsy is creating a high-resolution data map of heart disease, promising a new era of precision medicine.

By emphasizing deep anatomical knowledge, Medytox aims to elevate industry standards and solidify its leadership in Asia's booming medical aesthetics market.

Gifthealth won a top digital health award, but its real victory is in redefining the prescription journey with faster delivery and better patient outcomes.

Clinuvel's SCENESSE® advances to a pivotal Phase III trial with a novel EMA-backed design, focusing on patient experience and visible results.

Millions are using GLP-1 drugs for weight loss, but an unexpected side effect is emerging: a prominent 'buffalo hump' that surgery is now targeting.

A new collaboration aims to slash neurologist wait times from months to days, as pharma giant Lilly expands its digital health ecosystem for chronic care.

As GLP-1 costs cripple employer health plans, Noom Health's new program bypasses industry middlemen, projecting massive savings and better patient outcomes.

With its Nasdaq debut, Lakewood-Amedex aims to accelerate its novel antimicrobial, Nu-3, a new weapon against antibiotic-resistant diabetic foot ulcers.

With its CMO and CSO now both recipients of the AHA's top honor, Cardiovascular Clinical Sciences signals a rare concentration of elite expertise.

A new non-viral gene therapy targeting iron buildup in the eye has completed its Phase I trial, offering a potential new path for millions with dry AMD.